C12N 2770/20044
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2770/20044 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 3 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 8
- Assignees
- 7
- Inventors
- 19
- Latest grant
- 4 Jul 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 1 | 2 |
| 2023 | 2 | 2 |
| 2024 | 0 | 2 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Neutralizing antibody immunoassays4 Jul 2023US 11,693,011 B2InBios International, Inc.
- Vaccines against coronavirus and methods of use30 May 2023US 11,660,335 B2Inovio Pharmaceuticals, Inc.
- Hybrid alphavirus-SARS-CoV-2 particle and methodology of making and using same18 Oct 2022US 11,473,064 B2George Mason Research Foundation, Inc.
- Vaccines against coronavirus and methods of use17 Apr 2025US 2025/0121054 A1Inovio Pharmaceuticals, Inc.
- Flexible expression vector systems and application of same to vaccines and immunotherapeutics1 Aug 2024US 2024/0254515 A1The James Hutton Institute
- Compositions and methods for dominant antiviral therapy9 May 2024US 2024/0150413 A1Massachusetts Institute of Technology
- Neutralizing antibody immunoassays23 Nov 2023US 2023/0375568 A1InBios International, Inc.
- Vaccines against coronavirus and methods of use26 Oct 2023US 2023/0338515 A1Inovio Pharmaceuticals, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.